• LAST PRICE
    74.3500
  • TODAY'S CHANGE (%)
    Trending Down-2.4400 (-3.1775%)
  • Bid / Lots
    74.3300/ 2
  • Ask / Lots
    74.5300/ 4
  • Open / Previous Close
    77.1400 / 76.7900
  • Day Range
    Low 74.2500
    High 77.1400
  • 52 Week Range
    Low 55.0200
    High 98.4000
  • Volume
    216,638
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 76.79
TimeVolumeAXSM
09:32 ET340976.945
09:34 ET80076.27
09:36 ET83076.1
09:38 ET35076.052
09:41 ET45076.09
09:43 ET83275.85
09:45 ET180075.75
09:48 ET710075.74
09:50 ET98875.735
09:52 ET325975.5
09:54 ET60075.6
09:56 ET194375.39
09:57 ET30075.43
09:59 ET290075.595
10:01 ET280075.48
10:03 ET179575.17
10:06 ET70075.3
10:08 ET90075.0201
10:10 ET110075.15
10:12 ET130075.18
10:14 ET50075.195
10:15 ET50075.11
10:17 ET358375.475
10:21 ET20075.5274
10:24 ET248175.4
10:26 ET250075.465
10:28 ET45075.2801
10:30 ET20075.42
10:32 ET46575.1289
10:33 ET140075.425
10:35 ET120075.4922
10:37 ET123075.26
10:39 ET82575.53
10:42 ET10075.47
10:44 ET40075.7199
10:46 ET40075.55
10:48 ET45075.43
10:51 ET10075.53
10:53 ET50075.4526
10:55 ET10075.53
10:57 ET205175.22
11:00 ET10075.23
11:02 ET20075.345
11:04 ET25375.435
11:06 ET50075.49
11:09 ET150075.45
11:11 ET68375.495
11:13 ET50075.45
11:15 ET120075.585
11:18 ET60075.59
11:20 ET50375.51
11:22 ET30075.5
11:24 ET714475.97
11:26 ET220075.8
11:29 ET100075.7
11:31 ET105575.795
11:33 ET50075.79
11:36 ET99975.89
11:38 ET50075.935
11:40 ET20075.97
11:42 ET40075.88
11:44 ET23575.81
11:45 ET10075.905
11:49 ET20075.94
11:51 ET50075.94
11:54 ET100075.95
11:56 ET310775.9
11:58 ET30075.95
12:00 ET94976.14
12:02 ET50076.14
12:07 ET345076.26
12:09 ET53676.325
12:12 ET10076.34
12:14 ET10076.33
12:16 ET20076.25
12:18 ET20076.365
12:20 ET83976.21
12:27 ET32076.3
12:30 ET26676.27
12:36 ET10076.25
12:38 ET30076.18
12:39 ET20076.17
12:41 ET60076.05
12:43 ET10076.04
12:45 ET53576.04
12:48 ET70075.92
12:50 ET70075.92
12:52 ET226476.01
12:54 ET11576.02
12:56 ET10076.025
12:57 ET195075.86
12:59 ET39075.875
01:01 ET200075.865
01:03 ET20075.988
01:06 ET30075.925
01:10 ET20075.935
01:12 ET140075.87
01:14 ET70075.99
01:19 ET30075.89
01:21 ET40075.76
01:26 ET110075.725
01:28 ET50075.775
01:32 ET100775.7
01:35 ET30075.54
01:37 ET75075.38
01:39 ET10075.275
01:42 ET25875.33
01:44 ET54075.23
01:46 ET10075.065
01:48 ET20075.1
01:50 ET10075.15
01:51 ET20075.2
01:53 ET320375.2399
01:55 ET10075.12
01:57 ET187775.11
02:00 ET40075.085
02:02 ET1209274.61
02:04 ET189074.6291
02:06 ET40074.575
02:08 ET20074.74
02:09 ET80074.705
02:11 ET121874.69
02:13 ET100074.635
02:18 ET10074.72
02:20 ET236074.695
02:22 ET10074.7
02:24 ET230074.58
02:26 ET274574.585
02:27 ET140074.625
02:29 ET120074.475
02:33 ET30074.39
02:36 ET10074.345
02:38 ET141374.44
02:40 ET160074.515
02:44 ET30074.49
02:45 ET20074.41
02:47 ET50074.4101
02:49 ET70074.49
02:51 ET147474.33
02:54 ET190574.55
02:56 ET120074.41
02:58 ET284274.35
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAXSM
Axsome Therapeutics Inc
3.6B
-11.6x
---
United StatesINSM
Insmed Inc
3.6B
-4.5x
---
United StatesMOR
MorphoSys AG
2.8B
-5.4x
---
United StatesARWR
Arrowhead Pharmaceuticals Inc
3.1B
-5.8x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
2.8B
-10.8x
---
United StatesTGTX
TG Therapeutics Inc
2.7B
77.7x
---
As of 2024-05-23

Company Information

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity under development for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. AXS-07 is an oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine.

Contact Information

Headquarters
One World Trade Center, 22Nd FloorNEW YORK, NY, United States 10007
Phone
212-332-3241
Fax
212-320-0245

Executives

Chairman of the Board, President, Chief Executive Officer, Founder
Herriot Tabuteau
Chief Financial Officer
Nick Pizzie
Chief Operating Officer
Mark Jacobson
Executive Vice President - Commercial and Business Development
Lori Englebert
General Counsel
Hunter Murdock

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.6B
Revenue (TTM)
$251.0M
Shares Outstanding
47.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.26
EPS
$-6.38
Book Value
$4.03
P/E Ratio
-11.6x
Price/Sales (TTM)
14.5
Price/Cash Flow (TTM)
---
Operating Margin
-116.61%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.